{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-14",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20240322",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "77921",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761310Origs005lbl.pdf",
              "date": "20240322",
              "type": "Label"
            },
            {
              "id": "77947",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761310Orig1s005ltr.pdf",
              "date": "20240325",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20221114",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "72616",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761310s000lbl.pdf",
              "date": "20221114",
              "type": "Label"
            },
            {
              "id": "72617",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761310Orig1s000ltr.pdf",
              "date": "20221115",
              "type": "Letter"
            },
            {
              "id": "72801",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/761310Orig1s000TOC.html",
              "date": "20221207",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "10",
          "submission_status": "AP",
          "submission_status_date": "20250714",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ]
        }
      ],
      "application_number": "BLA761310",
      "sponsor_name": "IMMUNOGEN INC",
      "openfda": {
        "application_number": [
          "BLA761310"
        ],
        "brand_name": [
          "ELAHERE"
        ],
        "generic_name": [
          "MIRVETUXIMAB SORAVTANSINE"
        ],
        "manufacturer_name": [
          "ImmunoGen, Inc."
        ],
        "product_ndc": [
          "72903-853"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "MIRVETUXIMAB SORAVTANSINE"
        ],
        "rxcui": [
          "2621553",
          "2621559"
        ],
        "spl_id": [
          "47f1c78d-c469-4cd7-926e-51ce5b2d26f5"
        ],
        "spl_set_id": [
          "00c424b5-6ccd-48ab-9e88-1986451120e2"
        ],
        "package_ndc": [
          "72903-853-01"
        ],
        "unii": [
          "98DE7VN88D"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "ELAHERE",
          "active_ingredients": [
            {
              "name": "MIRVETUXIMAB SORAVTANSINE-GYNX",
              "strength": "100mg/20mL single-dose vial"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}